✦ LIBER ✦

Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancer

✍ Scribed by Patrick W. Sullivan; Parvez M. Mulani; Mayer Fishman; Darryl Sleep

Publisher: Springer Netherlands
Year: 2007
Tongue: English
Weight: 148 KB
Volume: 16
Category: Article
ISSN: 0962-9343
DOI: 10.1007/s11136-006-9156-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quality of life as a potential predictor

Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer

✍ Patrick W. Sullivan; Joel B. Nelson; Parvez M. Mulani; Darryl Sleep 📂 Article 📅 2006 🏛 Springer Netherlands 🌐 English ⚖ 183 KB

A phase I study of the somatostatin anal

A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone-refractory prostate cancer

✍ William D. Figg; Alain Thibault; Michael R. Cooper; Robert Reid; Donna Headlee; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

Quality of life in patients with prostat

Quality of life in patients with prostatic cancer a feasibility study

✍ F. Calais Da Silva; Elizabeth Reis; Telmo Costa; Louis Denis 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 478 KB 👁 3 views

a i d the Members of Quality of Life Committee of the EORTC Genitourinary Group Background. In recent years, there has been a growing recognition of the need to include parameters representing the patients' view of their conditions that, therefore, are more subjective in nature. As a first effort t

A comparison of the quality of life of p

A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy

✍ Harry W. Herr; Alice B. Kornblith; Ursula Ofman 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 452 KB 👁 2 views

Induction of Tc2 cells with specificity

Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer

✍ Supriya Perambakam; Bao-Hua Xue; Jeffrey A. Sosman; David J. Peace 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 174 KB

A phase 2 study of carboplatin plus doce

A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel

✍ Robert W. Ross; Tomasz M. Beer; Susanna Jacobus; Glenn J. Bubley; Mary-Ellen Tap 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## BACKGROUND. Prostate cancer is the second leading cause of cancer mortality among men in the U.S. To the authors' knowledge, there is no proven, effective, second‐line therapy for docetaxel‐refractory disease. Recent data suggest that platinum salts may be effective when combined wi